basis of disease – French Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot      16 Results   12 Domains
  www.oie.int  
Show textShow cached sourceOpen source URL
Legal basis of disease notification
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine oie.int as primary domain
Bases juridiques de la notification des maladies
  2 Hits www.agr.ca  
Show textShow cached sourceOpen source URL
Wu, N., Sarna, L.K., Hwang, S.Y., Zhu, Q., Wang, P., Siow, Y.L., and O, K. (2013). "Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(10), pp. 1560-1568.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine agr.ca as primary domain
Wu, N., Sarna, L.K., Hwang, S.Y., Zhu, Q., Wang, P., Siow, Y.L., et O, K. (2013). « Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding. », Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(10), p. 1560-1568. doi : 10.1016/j.bbadis.2013.04.024 Accès au texte intégral (en anglais seulement)
  www.listeriosis-listeriose.investigation-enquete.gc.ca  
Show textShow cached sourceOpen source URL
Wu, N., Sarna, L.K., Hwang, S.Y., Zhu, Q., Wang, P., Siow, Y.L., and O, K. (2013). "Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(10), pp. 1560-1568.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine listeriosis-listeriose.investigation-enquete.gc.ca as primary domain
Wu, N., Sarna, L.K., Hwang, S.Y., Zhu, Q., Wang, P., Siow, Y.L., et O, K. (2013). « Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding. », Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832(10), p. 1560-1568. doi : 10.1016/j.bbadis.2013.04.024
  2 Hits www.genomecanada.ca  
Show textShow cached sourceOpen source URL
We will continue to approach Canadian academic researchers and biopharmaceutical companies who are potential users of mouse embryonic stem cells in their research to understand the genetic basis of disease, discover and validate new targets, and accelerate the pathway to commercialization.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine genomecanada.ca as primary domain
We also developed novel plasmid shuffling techniques which can be used to generate new plasmids without the need to use restriction enzymes and ligases. We will continue to approach Canadian academic researchers and biopharmaceutical companies who are potential users of mouse embryonic stem cells in their research to understand the genetic basis of disease, discover and validate new targets, and accelerate the pathway to commercialization. We will use formal and informal business development channels and strategic marketing tools such as a brochure, website, and slide presentations tailored to specific audiences (academia, biopharmaceutical companies and venture capital firms). Publication regarding the development of the technologies will be sought in high impact international journals.
  people.epfl.ch  
Show textShow cached sourceOpen source URL
Introduction to the molecular and chemical basis of disease and therapy In the first part of the course the molecular and chemical basis of important human diseases and available therapies will be discussed.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine people.epfl.ch as primary domain
Introduction des mécanismes moléculaires et chimiques des maladies thérapeutiques Dans la première partie du cours, les mécanismes moléculaires et chimiques des maladies humaines importantes et des médicaments seront discutés. Dans la deuxième...
  www.health.gov.on.ca  
Show textShow cached sourceOpen source URL
The increasing ability to test for genetic predisposition to disease has resulted in optimism that genetic predictive testing will help improve treatments and health care delivery. An understanding of the genetic basis of disease is expected to help everyone better understand disease processes.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine health.gov.on.ca as primary domain
Au cours de la dernière décennie, la science a fait des pas de géant dans la découverte du génome humain. Des technologies poussées ont permis d'ébaucher, avec une précision sans précédent, une cartographie de la génétique humaine. La capacité accrue de dépistage des prédispositions génétiques à certaines pathologies fait espérer que les tests génétiques prédictifs améliorent la thérapeutique et la prestation des soins de santé. La découverte du fondement génétique de la maladie ne peut manquer d'éclairer les processus pathologiques.
  www.mcgill.ca  
Show textShow cached sourceOpen source URL
The Complex lays the foundation for medical and scientific researchers to uncover the biological basis of disease, translate research into better health and patient care, and train tomorrow’s leaders in the health sciences.
Compare text pagesCompare HTM pagesOpen source URLOpen target URLDefine mcgill.ca as primary domain
Avec l’ouverture des nouveaux pavillons de recherche, une aventure palpitante démarre pour les facultés de médecine et des sciences qui verront leurs forces se décupler en recherche biologique et médicale. Le Complexe des sciences de la vie de McGill est un établissement d’envergure internationale qui réunit de grands chercheurs et des outils modernes qui accéléreront le rythme de leurs découvertes. Le Complexe permettra aux médecins et aux chercheurs d’identifier les fondements biologiques de la maladie, d’utiliser la recherche pour améliorer la santé et les soins aux patients, et de former les chefs de file de l’avenir dans les sciences de la santé.